
ReWalk Robotics Ltd. RWLK
Annual report 2025
added 03-18-2026
ReWalk Robotics Ltd. Total Assets 2011-2026 | RWLK
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets ReWalk Robotics Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.9 M | 30.5 M | 63.2 M | 74.2 M | 94.8 M | 28.1 M | 24.4 M | 15 M | 22.9 M | 31.8 M | 25.6 M | 47.7 M | 11.1 M | 2.09 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 94.8 M | 2.09 M | 35.3 M |
Quarterly Total Assets ReWalk Robotics Ltd.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.2 M | 26.8 M | 28.8 M | 30.5 M | 45.8 M | 51 M | 55.2 M | 63.2 M | 69.2 M | 65.8 M | 69 M | 74.2 M | 80.8 M | 85.8 M | 90 M | 94.8 M | 98.7 M | 71.7 M | 74.6 M | 28.1 M | 28.1 M | 28.1 M | 28.1 M | 24.4 M | 24.4 M | 24.4 M | 24.4 M | 15 M | 15 M | 15 M | 15 M | 22.9 M | 22.9 M | 22.9 M | 22.9 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 25.6 M | 25.6 M | 25.6 M | 25.6 M | 47.7 M | - | - | - | 11.1 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 98.7 M | 11.1 M | 41.1 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
222 M | $ 32.81 | 5.87 % | $ 1.51 B | ||
|
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.36 | 3.48 % | $ 1.67 B | ||
|
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.39 | 3.53 % | $ 266 M | ||
|
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
5.81 B | $ 38.22 | 4.23 % | $ 5.7 K | ||
|
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | ||
|
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | ||
|
Electromed
ELMD
|
53.8 M | $ 24.45 | 2.8 % | $ 207 M | ||
|
FONAR Corporation
FONR
|
199 M | $ 18.61 | 0.13 % | $ 122 M | ||
|
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.38 | -0.59 % | $ 127 M | ||
|
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
6.21 B | $ 178.65 | 7.06 % | $ 13.4 B | ||
|
Globus Medical
GMED
|
5.3 B | $ 91.76 | 1.91 % | $ 12.4 B | ||
|
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M | ||
|
Butterfly Network
BFLY
|
256 M | $ 4.2 | 3.33 % | $ 889 M | ||
|
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | ||
|
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.91 | 4.37 % | $ 1.16 M | ||
|
Nevro Corp.
NVRO
|
554 M | - | - | $ 217 M | ||
|
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.64 | 4.94 % | $ 39.8 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.69 | 3.86 % | $ 746 M | ||
|
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
124 M | $ 9.87 | 2.02 % | $ 354 M | ||
|
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
43.7 B | $ 62.67 | 1.33 % | $ 92.8 B | ||
|
Alphatec Holdings
ATEC
|
791 M | $ 11.53 | 4.49 % | $ 1.73 B | ||
|
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.14 | 10.19 % | $ 19.3 M | ||
|
CONMED Corporation
CNMD
|
2.33 B | $ 36.63 | 5.96 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
3.41 B | $ 87.27 | 2.49 % | $ 3.03 B | ||
|
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.33 | 3.62 % | $ 383 M | ||
|
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 82.18 | 1.68 % | $ 48.1 B | ||
|
Inspire Medical Systems
INSP
|
907 M | $ 53.86 | -1.01 % | $ 1.58 B | ||
|
LivaNova PLC
LIVN
|
2.61 B | $ 64.88 | 2.11 % | $ 3.54 B | ||
|
LENSAR
LNSR
|
71.4 M | $ 5.7 | 1.24 % | $ 68.2 M |